The American Cancer Society recently updated its colorectal cancer screening guideline for the first time since 2018 by ...

The new study results could make Abbott, which has an agreement with Freenome to market the blood-based test, the dominant ...

One analyst called the insurer’s decision a “watershed moment” for liquid biopsy-based cancer screening and for the category ...

In July 2026, Guardant Health announced that its Shield blood test for colorectal cancer screening is now covered for ...

A host of companies are competing to bring cancer-detecting blood tests to market.

The updated test showed 80 percent sensitivity for detecting colorectal cancer overall and 18 percent sensitivity for advanced precancerous lesions.

A new blood test for colorectal cancer screening is being implemented in Alabama to improve early detection and reduce deaths from the disease.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield™ blood test for colorectal cancer screening (CRC) is now covered for eligible UnitedHealth Group ...

Colorectal cancer is one of the most common cancers in the world and is also one of the leading causes of cancer deaths. It ...